This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Raymond Frost
Senior Vice President, Market Access at Cogent Biosciences
Speaker

Profile

Prior to joining Cogent, Mr. Frost served as Vice President Market Access at Ono Pharma USA. Prior to Ono Pharma he served as Vice President US & Global Market Access at Zealand Pharma. While at Zealand he played an integral part of building the commercial infrastructure to support the launch of their first drug. Before Zealand Pharma he was the Vice President of Market Access & Health Policy at Melinta Therapeutics & The Medicines Company. During his time at Melinta and The Medicines Company he launched four drugs into the market and helped build a commercial infrastructure to support those launches. He graduated from Hofstra University, Long Island, New York.

Agenda Sessions

  • Breaking Through the Noise – Winning in Competitive Rare Disease Markets

    1:30pm